GlassScriptPhysician profile
Linda Suzanne Basler
NPI 1528561370
$3,603.70
in general payments reported to CMS, 2019-2025
29 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $779 · 2023: $864 · 2024: $816 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,224.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $441.75 | 2021-2025 | Jot Dx, Amplatzer Talisman, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $414.23 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $330.61 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.97 | 2022-2025 | Jardiance |
| Amgen INC. | $247.94 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $241.26 | 2021-2024 | |
| Medtronic, INC. | $201.15 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra |
| E.R. Squibb & Sons, L.L.C. | $193.08 | 2021-2025 | Eliquis, Camzyos |
| Abiomed | $191.28 | 2024-2025 | Impella |
| Pfizer INC. | $164.56 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $163.59 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $131.60 | 2021-2025 | Wainua, Farxiga |
| Edwards Lifesciences Corporation | $71.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.77 | 2022-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $66.29 | 2023 | Arcalyst |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $49.04 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $35.13 | 2021-2022 | |
| Abbvie INC. | $34.08 | 2024 | |
| Angiodynamics, INC. | $32.68 | 2024 | Auryon Laser System 100-120 Vac |
| Sanofi-Aventis U.S. LLC | $30.26 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $28.56 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $28.47 | 2024 | Arcalyst |
| Boston Scientific Corporation | $20.45 | 2022 | |
| Koya Medical, INC. | $18.05 | 2025 | Dayspring, Koya Medical |
| Novo Nordisk INC | $15.95 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $15.66 | 2023 | |
| Esperion Therapeutics, INC. | $15.27 | 2021 | |
| Kestra Medical Technology Services, INC. | $15.00 | 2024 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $13.50 | 2025 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Basler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.